4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-043011
Director sold 2,000 shares at an average $43.85 ($87,690)
- Director acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT Director | 2020-07-15 | Option exercise | +2,000 | $0.45 | $900 | 2,000 | D: show line 1 in the form |
| HERSHBERG ROBERT Director | 2020-07-15 | Sale | −1,500 | $43.60 | $65,400 | 500 | D: show line 2 in the form |
| HERSHBERG ROBERT Director | 2020-07-15 | Sale | −500 | $44.58 | $22,290 | 0 | D: show line 3 in the form |
| Open-market sales · 2,000 sh · avg $43.85 · $87,690 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| HERSHBERG ROBERT Director | 2020-07-15 | Option exercise · Stock Option (Right to Buy) | −2,000 | 69,000 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…